The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

P. Jain, H. Kantarjian, F. Ravandi, D. Thomas, S. O'Brien, T. Kadia, J. Burger, G. Borthakur, N. Daver, E. Jabbour, M. Konopleva, J. Cortes, N. Pemmaraju, M. A. Kelly, M. Cardenas-Turanzas, R. Garris, S. Faderl

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)973-975
Number of pages3
JournalLeukemia
Volume28
Issue number4
DOIs
StatePublished - Apr 2014
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma : MD Anderson Cancer Center experience. / Jain, P.; Kantarjian, H.; Ravandi, F.; Thomas, D.; O'Brien, S.; Kadia, T.; Burger, J.; Borthakur, G.; Daver, N.; Jabbour, E.; Konopleva, M.; Cortes, J.; Pemmaraju, N.; Kelly, M. A.; Cardenas-Turanzas, M.; Garris, R.; Faderl, S.

In: Leukemia, Vol. 28, No. 4, 04.2014, p. 973-975.

Research output: Contribution to journalLetter

Jain, P, Kantarjian, H, Ravandi, F, Thomas, D, O'Brien, S, Kadia, T, Burger, J, Borthakur, G, Daver, N, Jabbour, E, Konopleva, M, Cortes, J, Pemmaraju, N, Kelly, MA, Cardenas-Turanzas, M, Garris, R & Faderl, S 2014, 'The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience', Leukemia, vol. 28, no. 4, pp. 973-975. https://doi.org/10.1038/leu.2013.312
Jain, P. ; Kantarjian, H. ; Ravandi, F. ; Thomas, D. ; O'Brien, S. ; Kadia, T. ; Burger, J. ; Borthakur, G. ; Daver, N. ; Jabbour, E. ; Konopleva, M. ; Cortes, J. ; Pemmaraju, N. ; Kelly, M. A. ; Cardenas-Turanzas, M. ; Garris, R. ; Faderl, S. / The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma : MD Anderson Cancer Center experience. In: Leukemia. 2014 ; Vol. 28, No. 4. pp. 973-975.
@article{4585e54075fe429587e20a10c089103a,
title = "The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience",
author = "P. Jain and H. Kantarjian and F. Ravandi and D. Thomas and S. O'Brien and T. Kadia and J. Burger and G. Borthakur and N. Daver and E. Jabbour and M. Konopleva and J. Cortes and N. Pemmaraju and Kelly, {M. A.} and M. Cardenas-Turanzas and R. Garris and S. Faderl",
year = "2014",
month = "4",
doi = "10.1038/leu.2013.312",
language = "English (US)",
volume = "28",
pages = "973--975",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma

T2 - MD Anderson Cancer Center experience

AU - Jain, P.

AU - Kantarjian, H.

AU - Ravandi, F.

AU - Thomas, D.

AU - O'Brien, S.

AU - Kadia, T.

AU - Burger, J.

AU - Borthakur, G.

AU - Daver, N.

AU - Jabbour, E.

AU - Konopleva, M.

AU - Cortes, J.

AU - Pemmaraju, N.

AU - Kelly, M. A.

AU - Cardenas-Turanzas, M.

AU - Garris, R.

AU - Faderl, S.

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84898402916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898402916&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.312

DO - 10.1038/leu.2013.312

M3 - Letter

C2 - 24157581

AN - SCOPUS:84898402916

VL - 28

SP - 973

EP - 975

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -